Glycerophosphorylethanolamine (GPEA) identified as an hepatocyte growth stimulator in liver extracts.
Extracts from weanling pig liver were found to act synergistically with growth factors such as hepatocyte growth factor and transforming growth factor-alpha to stimulate hepatocyte growth in serum-free cultures. In the absence of added growth factors, the extracts had no activity. The compound responsible for this activity was isolated by passing heat-treated liver extract through anion-exchange and heparin columns followed by gel filtration at neutral and low pH, reversed-phase HPLC, and a final gel filtration column at low pH. The activity was followed throughout the purification by its ability to increase substantially the incorporation of [3H]thymidine into primary rat hepatocytes cultured serum-free in the presence of hepatocyte growth factor. The active compound was identified by NMR and mass spectrometry as glycerophosphorylethanolamine (GPEA), a breakdown product of the phospholipid phosphatidylethanolamine. The ethanolamine portion of the molecule was critical for the observed activity, whereas the glycerol phosphate portion was not necessary. In the absence of added growth factors, neither GPEA nor ethanolamine had any stimulatory effect on the cells. These results demonstrate that hepatocytes grown in culture, and especially those grown in serum-free media, require a supplement of ethanolamine and/or GPEA. In the absence of these compounds, their response to growth stimuli is greatly reduced.
Nelson
C
C
Genentech, Incorporated, South San Francisco, California 94080, USA.
Moffat
B
B
Jacobsen
N
N
Henzel
W J
WJ
Stults
J T
JT
King
K L
KL
McMurtrey
A
A
Vandlen
R
R
Spencer
S A
SA
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D002846:Chromatography, Affinity; D002852:Chromatography, Ion Exchange; D004247:DNA / Q000096:biosynthesis; D004357:Drug Synergism; D019856:Ethanolamine; D004983:Ethanolamines / Q000494:pharmacology; D005260:Female; D006133:Growth Substances / Q000494:pharmacology*; D017228:Hepatocyte Growth Factor / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D008099:Liver / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D010714:Phosphatidylethanolamines / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology* / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000494:pharmacology; D013552:Swine; D013936:Thymidine / Q000378:metabolism; D014020:Tissue Extracts / Q000737:chemistry; D016211:Transforming Growth Factor alpha / Q000494:pharmacology
D004983:Ethanolamines; D006133:Growth Substances; D010714:Phosphatidylethanolamines; D011994:Recombinant Proteins; D014020:Tissue Extracts; D016211:Transforming Growth Factor alpha; C002449:glycerophosphoethanolamine; D019856:Ethanolamine; D017228:Hepatocyte Growth Factor; D004247:DNA; D013936:Thymidine